Cellebrite DI (CLBT) Equity Ratio (2020 - 2025)

Cellebrite DI has reported Equity Ratio over the past 6 years, most recently at 0.52 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.52 for Q4 2025, up 6.02% from a year ago — trailing twelve months through Dec 2025 was 0.52 (up 6.02% YoY), and the annual figure for FY2025 was 0.52, up 6.02%.
  • Equity Ratio for Q4 2025 was 0.52 at Cellebrite DI, up from 0.49 in the prior quarter.
  • Over the last five years, Equity Ratio for CLBT hit a ceiling of 0.52 in Q4 2025 and a floor of 0.22 in Q4 2021.
  • Median Equity Ratio over the past 5 years was 0.18 (2022), compared with a mean of 0.21.
  • Biggest five-year swings in Equity Ratio: tumbled 223.28% in 2021 and later surged 657.9% in 2024.
  • Cellebrite DI's Equity Ratio stood at 0.22 in 2021, then skyrocketed by 184.85% to 0.18 in 2022, then tumbled by 64.95% to 0.06 in 2023, then surged by 657.9% to 0.49 in 2024, then increased by 6.02% to 0.52 in 2025.
  • The last three reported values for Equity Ratio were 0.52 (Q4 2025), 0.49 (Q4 2024), and 0.06 (Q4 2023) per Business Quant data.